Xiamen Amoytop Biotech (688278.SH) plans to issue convertible bonds to raise no more than 1.533 billion yuan.

21:35 26/01/2026

TeBao Biotechnology (688278.SH) announced that the company plans to issue convertible bonds to unspecified investors, raising a total amount of funds not exceeding 1.533 billion yuan (including issuance expenses). The net proceeds from the fundraising, after deducting the issuance expenses, will be used for: new drug research and development projects, construction projects of the Biotechnology Innovation Integration Center, and the expansion project of TeBao Biotechnology's innovative drug production line.

Xiamen Amoytop Biotech (688278.SH) announced that the company plans to issue convertible bonds to unspecified investors, raising a total amount of funds not exceeding 1.533 billion yuan (including issuance expenses). The net proceeds from the issuance, after deducting issuance expenses, will be used for: new drug research projects, construction projects for innovative biotechnology integration center, and the expansion project of Xiamen Amoytop Biotech's innovative drug production line construction.

FULLSHARE (00607) intends to discount approximately 20% to issue 127 million subscribed shares, raising a net of approximately HK$1.32 billion.

HOMELAND ITL(03798) subscription and redemption of wealth management products

GR LIFE STYLE (00108) signs a strategic cooperation memorandum with Mingzhi Medical to jointly promote the in-depth integration and industrial upgrading of "medical + technology + scenarios".

FULLSHARE (00607) intends to discount approximately 20% to issue 127 million subscribed shares, raising a net of approximately HK$1.32 billion.

HOMELAND ITL(03798) subscription and redemption of wealth management products

GR LIFE STYLE (00108) signs a strategic cooperation memorandum with Mingzhi Medical to jointly promote the in-depth integration and industrial upgrading of "medical + technology + scenarios".